China Life Valuation
CILJF Stock | USD 1.93 0.03 1.58% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. China Life Insurance shows a prevailing Real Value of $1.88 per share. The current price of the firm is $1.93. Our model approximates the value of China Life Insurance from analyzing the firm fundamentals such as Current Valuation of 133.38 B, return on equity of 0.0747, and Profit Margin of 0.04 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that China Life's price fluctuation is unstable at this time. Calculation of the real value of China Life Insurance is based on 3 months time horizon. Increasing China Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Life Insurance. Since China Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 1.93 | Real 1.88 | Hype 1.93 | Naive 1.86 |
The real value of China Pink Sheet, also known as its intrinsic value, is the underlying worth of China Life Insurance Company, which is reflected in its stock price. It is based on China Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Life Insurance helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Life more accurately as focusing exclusively on China Life's fundamentals will not take into account other important factors: China Life Total Value Analysis
China Life Insurance is currently forecasted to have takeover price of 133.38 B with market capitalization of 114.63 B, debt of 53.68 B, and cash on hands of 309.41 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the China Life fundamentals before making investing decisions based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
133.38 B | 114.63 B | 53.68 B | 309.41 B |
China Life Investor Information
About 23.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.63. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Life Insurance has Price/Earnings To Growth (PEG) ratio of 1.2. The entity last dividend was issued on the 6th of July 2022. Based on the measurements of operating efficiency obtained from China Life's historical financial statements, China Life Insurance is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.China Life Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of China implies not a very effective usage of assets in February.China Life Ownership Allocation
China Life holds a total of 7.44 Billion outstanding shares. Almost 76.91 percent of China Life outstanding shares are held by general public with 23.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.China Life Profitability Analysis
The company reported the revenue of 824.93 B. Net Income was 50.92 B with profit before overhead, payroll, taxes, and interest of 123.66 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Life and how it compares across the competition.
About China Life Valuation
The pink sheet valuation mechanism determines China Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Life. We calculate exposure to China Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Life's related companies.China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the Peoples Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance Company Limited. China Life operates under InsuranceLife classification in the United States and is traded on OTC Exchange. It employs 102195 people.
8 Steps to conduct China Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain China Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine China Life's revenue streams: Identify China Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research China Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish China Life's growth potential: Evaluate China Life's management, business model, and growth potential.
- Determine China Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
China Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as China Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding | 28.3 B | |
Quarterly Earnings Growth Y O Y | -0.251 | |
Forward Price Earnings | 6.3694 | |
Retained Earnings | 345.7 B |
Complementary Tools for China Pink Sheet analysis
When running China Life's price analysis, check to measure China Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Life is operating at the current time. Most of China Life's value examination focuses on studying past and present price action to predict the probability of China Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Life's price. Additionally, you may evaluate how the addition of China Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |